Clinical Trial Update: Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea [Phase 1]

View source ↗

Summary

Phase 1 safety study of a capsule-conjugate vaccine intended to prevent Campylobacter-caused diarrhea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Campylobacter Infection

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Campylobacter Infection | Phase 1 | Status: COMPLETED | Results posted: 2018-01-25